True Wealth Design’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478 Sell
5
-4
-44% -$364 ﹤0.01% 2216
2026
Q1
$867 Hold
9
﹤0.01% 1858
2025
Q4
$876 Hold
9
﹤0.01% 1756
2025
Q3
$641 Buy
9
+5
+125% +$333 ﹤0.01% 1926
2025
Q2
$240 Hold
4
﹤0.01% 2014
2025
Q1
$210 Buy
+4
New +$225 ﹤0.01% 1932

Other funds holding IRMD

True Wealth Design's IRMD Position: Q2 2026 in Review

True Wealth Design reduced its iRadimed (IRMD) stake by 44% in Q2 2026, selling an estimated $364 and leaving 5 shares worth $478. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

True Wealth Design first reported a position in IRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $876 in Q4 2025. 22 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • True Wealth Design held 5 shares of iRadimed worth $478 as of Q2 2026.
  • True Wealth Design sold 4 iRadimed shares in Q2 2026, an estimated $364.
  • iRadimed made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2216 holding.
  • True Wealth Design first reported a position in iRadimed in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's iRadimed position peaked at $876 in Q4 2025.
  • 22 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.